RAMSAY HEALTH CARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.09 AUD | -0.97% |
|
-3.95% | -4.79% |
| Mar. 29 | JPMorgan Downgrades Ramsay Health Care to Underweight from Neutral; Price Target is AU$50 | MT |
| Mar. 11 | Australian shares fall as miners, banks weigh | RE |
| Sales 2024 * | 16.79B 10.76B | Sales 2025 * | 17.61B 11.28B | Capitalization | 11.57B 7.42B |
|---|---|---|---|---|---|
| Net income 2024 * | 630M 404M | Net income 2025 * | 460M 295M | EV / Sales 2024 * | 1.13 x |
| Net Debt 2024 * | 7.4B 4.74B | Net Debt 2025 * | 7.27B 4.66B | EV / Sales 2025 * | 1.07 x |
| P/E ratio 2024 * |
19.4
x | P/E ratio 2025 * |
25.8
x | Employees | 88,000 |
| Yield 2024 * |
1.72% | Yield 2025 * |
2.35% | Free-Float | 77.18% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ramsay Health Care Limited
More recommendations
More press releases
| 1 day | -0.97% | ||
| 1 week | -3.67% | ||
| Current month | -11.36% | ||
| 1 month | -7.63% | ||
| 3 months | +0.78% | ||
| 6 months | -0.79% | ||
| Current year | -4.79% |
1 week
49.57
52.09
1 month
49.5756.67
Current year
48.9557.23
1 year
46.7666.83
3 years
46.7684.58
5 years
46.1284.58
10 years
43.7084.58
| Managers | Title | Age | Since |
|---|---|---|---|
Craig McNally
CEO | Chief Executive Officer | 63 | 87-12-31 |
Martyn Roberts
DFI | Director of Finance/CFO | 56 | 20-04-19 |
Edward Byrne
CTO | Chief Tech/Sci/R&D Officer | 72 | 21-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Siddle
BRD | Director/Board Member | - | 67-12-31 |
Steven Sargent
BRD | Director/Board Member | 62 | 21-11-24 |
David Thodey
CHM | Chairman | 70 | 17-11-27 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.90% | 231 M€ | -1.00% | ||
| 0.90% | 1 M€ | -.--% | - | |
| 0.37% | 121 M€ | -0.87% | - | |
| 0.28% | 18 M€ | +1.40% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 50.09 | -0.97% | 332 669 |
| 24-04-18 | 50.58 | -0.98% | 273,988 |
| 24-04-17 | 51.08 | -0.78% | 240,840 |
| 24-04-16 | 51.48 | -0.83% | 500,655 |
| 24-04-15 | 51.91 | -0.17% | 327,115 |
Delayed Quote Australian S.E., April 19, 2024 at 02:10 am EDT
More quotes
Ramsay Health Care Limited is an Australia-based company that provides healthcare to people through a network of hospitals, clinics and services in Australia, Asia, Europe and the United Kingdom. The Companyâs segments include Asia Pacific, UK, France and Nordics. Its businesses include Ramsay Australia, Ramsay Sante, Ramsay UK, and Elysium Healthcare. Ramsay Australia has over 73 private hospitals and day surgery units in Australia. Ramsay Sante is a private care provider in Europe and operates 443 multidisciplinary hospitals and clinics and 130 primary care centers across five countries. Ramsay UK has a network of 34 acute hospitals and day procedure centers in England providing a comprehensive range of clinical specialties to private and self-insured patients. Elysium Healthcare is an independent sector provider of specialist health and care services. Its four core service streams are mental health, neurological, learning disabilities and children and education.
Calendar
2024-08-29
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
50.58
AUD
Average target price
57.22
AUD
Spread / Average Target
+13.12%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.79% | 7.45B | |
| -21.49% | 16.01B | |
| +0.90% | 12.09B | |
| +1.00% | 11.21B | |
| +8.16% | 10.45B | |
| +17.84% | 7.87B | |
| +22.00% | 7.27B | |
| +3.81% | 6.63B | |
| +43.14% | 4.41B | |
| -1.16% | 4.42B |
- Stock Market
- Equities
- RHC Stock
